Institution

University of Virginia

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · PHASE 3 TRIAL

Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

ClinicalTrials.gov

Phase 3 RCT with completed recruitment (437 participants) addressing a significant clinical question, but this registry record reports no results; evidence strength cannot be assessed without outcome data.

PreliminaryUniversity of Virginia Tuberculosis HIV I Infection

Reported

Sample size437

Primary endpoint28-day Mortality

Primary outcome assessment timepo…28 days from enrollment

AUG 13, 2026 · INTERVENTIONAL STUDY

Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors

ClinicalTrials.gov

This is a completed registry record for a pilot study of digital micro-interventions in breast cancer survivors; recruitment is finished but no results are reported in this registry entry.

PreliminaryUniversity of Virginia NCT07160439 Digital Micro-Interventions

Reported

Sample size120

Primary outcome measureEvaluation of Digital Micro-Intervention, P…

Recruitment statusCOMPLETED

AUG 11, 2026 · PHASE 4 TRIAL

Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction

ClinicalTrials.gov

This is a recruiting interventional trial testing novel cardiac MRI methods and exploring GLP-1 agonism in HFpEF; no results are posted in this registry record.

PreliminaryNCT07178145 University of Virginia Heart Failure Preserved Ejection Fraction

Reported

Planned enrollment192

Study phasePHASE4

Primary outcome measureEpicardial adipose tissue fatty acid compos…